×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INTS – intensity therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INTS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
08:06 am
ints
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
Low
Report
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
11/21
08:00 am
ints
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement
Medium
Report
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement
11/18
08:12 am
ints
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
Medium
Report
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
11/18
08:00 am
ints
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
Low
Report
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS
11/13
04:12 pm
ints
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/13
04:06 pm
ints
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/8
08:06 am
ints
Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society (Sarcomas) Meeting [Yahoo! Finance]
Low
Report
Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society (Sarcomas) Meeting [Yahoo! Finance]
11/8
08:01 am
ints
Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society (Sarcomas) Meeting
Low
Report
Intensity Therapeutics Selected for Oral Podium Presentation in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society (Sarcomas) Meeting
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2024
04:06 pm
ints
intensity therapeutics, inc.
BEAT
Report
2.4%
intensity therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
05:21 pm
ints
Form 424B5 INTENSITY THERAPEUTICS,
Medium
Report
Form 424B5 INTENSITY THERAPEUTICS,
11/13
04:11 pm
ints
Form 8-K INTENSITY THERAPEUTICS, For: Nov 13
Low
Report
Form 8-K INTENSITY THERAPEUTICS, For: Nov 13
11/13
04:01 pm
ints
Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30
Low
Report
Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30
10/23
04:23 pm
ints
Form 4 INTENSITY THERAPEUTICS, For: Oct 21 Filed by: Wesolowski John M
Low
Report
Form 4 INTENSITY THERAPEUTICS, For: Oct 21 Filed by: Wesolowski John M
10/23
04:21 pm
ints
Form 4 INTENSITY THERAPEUTICS, For: Oct 21 Filed by: Talamo Joseph
Low
Report
Form 4 INTENSITY THERAPEUTICS, For: Oct 21 Filed by: Talamo Joseph
10/23
04:20 pm
ints
Form 8-K INTENSITY THERAPEUTICS, For: Oct 21
Low
Report
Form 8-K INTENSITY THERAPEUTICS, For: Oct 21
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: